Mirador Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mirador Capital Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,477	Closed	-$313K	–	212
2024 Q4	$313K	Sell	3,477 -146	-4%	-$14.1K	0.06%	156
2024 Q3	$358K	Buy	+3,623	New	+$356K	0.06%	154
2023 Q4	–	Sell	-3,402	Closed	-$248K	–	204
2023 Q3	$248K	Sell	3,402 -823	-19%	-$65.7K	0.06%	160
2023 Q2	$352K	Buy	+4,225	New	+$353K	0.08%	145

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Mirador Capital Partners's XBI Position: Q1 2025 in Review

Mirador Capital Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 3,477 shares — an estimated $313K sold.

Mirador Capital Partners first reported a position in XBI in Q2 2023 and held it in 4 quarters. The position peaked at $358K in Q3 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Mirador Capital Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Mirador Capital Partners sold 3,477 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $313K.
Mirador Capital Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 4 quarters.
Mirador Capital Partners's State Street SPDR S&P Biotech ETF position peaked at $358K in Q3 2024.
682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Mirador Capital Partners's 13F filing for Q1 2025, filed 9 Apr 2025.